Watch RAPP. Know when insiders buy.
One email the day a filing lands. Free.
RAPP
Rapport Therapeutics, Inc.
25.06
−4.31 −14.67%
USD · close Oct 21
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
40
WATCH · insiders 30, shorts 49
Insiders, 90 days
−$4.3M
net selling · 1 buy, 14 sells
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $1.2BP/E —DIV YIELD —FCF YIELD -8.08%REV TTM —NET INCOME −$137.2MNET CASH —52W 24.37 – 52.50NEXT EARNINGS Nov 5 EST.SEC XBRL · TTM TO Invalid Date
One year, everything drawn on
Insider buyInsider sellCongress buy, above the lineCongress sell, below10-K / 10-Q filedHOVER A MARKER FOR THE FILING
THE WORK ORDER · 2026-10-22
Insiders (90d): $4.3M net selling · 1 distinct buyer
Shorts (latest report): 2.2M short · +8K last period
Every line of the math40WATCH
Insider activity
ALL 15| Date | Insider | Type | Value |
|---|---|---|---|
| Oct 21 | Chief Financial Officer | Buy | $144K |
| Oct 7 | Chief Executive Officer | Sell | $35K |
| Oct 6 | Chief Executive Officer | Sell | $108K |
| Sep 30 | Chief Operating Officer | Sell | $70K |
| Sep 30 | Chief Operating Officer | Sell | $262K |
| Sep 23 | Chief Executive Officer | Sell | $2K |